Kuehn Law Investigates Kymera Therapeutics Officers and Directors for Potential Fiduciary Breaches

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Kuehn Law, PLLC is investigating whether certain officers and directors of Kymera Therapeutics, Inc. breached their fiduciary duties to shareholders. The shareholder litigation law firm is examining potential self-dealing and says shareholders may be entitled to damages and corporate governance reforms. Long-term KYMR stockholders are encouraged to contact Justin Kuehn, Esq. by email or phone for a free consultation, with the firm covering all case costs.

Impact on assets 1

Biotech & Genomic Medicine▼
Kymera Therapeutics Inc
KYMR
▼ NegativeRegulationrelevance

Investigation for fiduciary breaches and potential self-dealing by officers/directors